Search This Blog

Friday, November 8, 2019

Recro Pharma EPS misses by $0.03, beats on revenue

Recro Pharma (NASDAQ:REPH): Q3 GAAP EPS of -$0.19 misses by $0.03.
Revenue of $25.26M (+38.2% Y/Y) beats by $4.67M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)